At 21.1% CAGR, Medical Tourism Market Size Worth $53.51 Billion…

At 21.1% CAGR, Medical Tourism Market Size Worth $53.51 Billion…

Facebook
Twitter
LinkedIn

PUNE, India, December 13, 2022 (GLOBE NEWSWIRE) — The global Size of the medical tourism market was valued at $11.56 billion in 2020. The market is expected to grow from USD 13.98 billion in 2021 to USD 53.51 billion in 2028, registering a CAGR of 21.1% during the forecast period 2021-2028. Dramatic advances in the healthcare sector, fueled by the introduction of novel medical devices and non-invasive procedures, are fueling the global rise of medical tourism.

Fortune Business Insights™ mentions this information in its report titled Medical Tourism Market Forecast, 2021-2028.

industry development

April 2021 – HexTransforma Healthcare introduced Brit-Med – a novel medical tourism platform – to enable patients worldwide to search, compare and receive the treatment they want.

November 2021 – Egypt announced the launch of a program aimed at providing advanced medical and therapeutic services to foreign patients.

Request a sample copy of the report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-tourism-market-100681

Report scope:

report coverage details
forecast period 2021 to 2028
Forecast period 2021 to 2028 CAGR 21.1%
Value prognosis 2028 $53.51 billion
base year 2020
Market size in 2021 $13.98 billion
Historical data 2017 to 2019
number of pages 155

Increase in inbound medical travel due to low-cost care to drive market growth

The growth of the medical tourism market is accelerated by the expansion of inbound medical travel. Continuous developments in healthcare related to medical devices, wearables, surgical procedures and connected technologies have enabled better healthcare. Telemedicine, telehealth and other technologies enable patients to book appointments, consult doctors and receive quality care from anywhere in the world. These factors have led to an increase in medical entry travel in developing countries such as India and Thailand.

The lower cost of treatment in developing countries compared to developed countries will…

[ad_2]

Source story

More to explorer